The Company is a healthcare solution provider dedicated to the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.
The Company focuses on enhancing ability to attract, incentivize and maintain good relationships with talented professionals. The Company believes its success greatly depends on the ability to attract, incentivize and maintain long-term relationships with talented professionals. In addition, the Company aims to keep long-term relationships with third-party development teams or experts.
The Company continues to invest in research and development. The Company attributes part of its success to our continued investment in and focus on R&D.
The Company offers personalized and inclusive services that catered to the specific requirements of its clients.
我們是一家醫(yī)療解決方案提供商，致力于開(kāi)發(fā)和商業(yè)化專門(mén)用于放射性粒籽植入的近距離治療計(jì)劃軟件，粒籽植入治療一種通過(guò)在患者體內(nèi)放置放射源來(lái)殺死癌細(xì)胞和縮小腫瘤的治療癌癥患者的放射療法。
公司注重提高吸引、激勵(lì)人才并與之保持良好關(guān)系的能力。公司相信其成功在很大程度上取決于吸引、激勵(lì)和保持與有才能的專業(yè)人士的長(zhǎng)期關(guān)系的能力。此外，公司旨在與第三方開(kāi)發(fā)團(tuán)隊(duì)或?qū)＜冶３珠L(zhǎng)期合作關(guān)系。
公司持續(xù)投資研究開(kāi)發(fā)。公司的成功部分歸功于其對(duì)研發(fā)的持續(xù)投資和專注。
公司提供根據(jù)客戶的具體要求提供個(gè)性化和包容性的服務(wù)。
